Themis Medicare

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE083B01024
  • NSEID: THEMISMED
  • BSEID: 530199
INR
105.79
-0.66 (-0.62%)
BSENSE

Dec 05

BSE+NSE Vol: 41.99 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
405.51
381.76
354.32
394.61
230.67
201.59
183.75
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
405.51
381.76
354.32
394.61
230.67
201.59
183.75
Raw Material Cost
76.31
84.67
96.04
113.63
67.92
51.38
49.23
Purchase of Finished goods
73.67
53.61
30.12
31.45
11.55
15.30
19.58
(Increase) / Decrease In Stocks
-17.98
-1.57
-7.79
3.06
-0.90
-3.49
-0.50
Employee Cost
96.38
82.41
66.15
51.97
39.99
44.28
45.69
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
0.00
0.01
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
128.09
111.13
102.37
98.87
62.60
58.47
67.48
Total Expenditure (Excl Depreciation)
356.46
330.25
286.88
298.98
181.17
165.93
181.48
Operating Profit (PBDIT) excl Other Income
49.05
51.51
67.44
95.63
49.50
35.66
2.27
Other Income
4.67
4.76
11.50
6.54
3.62
3.46
2.67
Operating Profit (PBDIT)
53.72
56.27
78.94
102.17
53.12
39.12
4.94
Interest
10.04
9.38
9.56
8.77
12.71
12.88
11.82
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
43.68
46.89
69.38
93.40
40.41
26.24
-6.88
Depreciation
9.93
12.25
10.49
9.48
8.55
8.27
7.99
Profit Before Tax
33.74
34.63
58.89
83.92
31.86
17.96
-14.87
Tax
9.84
9.92
15.61
22.38
5.63
2.09
-1.84
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
23.90
24.71
43.28
61.54
26.23
15.87
-13.03
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
23.90
24.71
43.28
61.54
26.23
15.87
-13.03
Share in Profit of Associates
5.93
18.81
13.62
11.34
9.47
8.91
2.27
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.02
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
29.83
43.52
56.90
72.88
35.70
24.78
-10.74
Equity Capital
9.20
9.20
9.20
9.20
9.19
9.19
9.18
Face Value
1.0
1.0
10.0
10.0
10.0
10.0
10.0
Reserves
360.43
335.09
296.47
244.12
174.75
138.86
113.54
Earnings per share (EPS)
3.24
4.73
6.19
79.22
38.85
26.96
-11.7
Diluted Earnings per share
3.24
4.72
61.73
79.07
38.84
26.97
-11.72
Operating Profit Margin (Excl OI)
12.1%
13.49%
19.03%
24.23%
21.46%
17.69%
1.24%
Gross Profit Margin
10.77%
12.28%
19.58%
23.67%
17.52%
13.02%
-3.74%
PAT Margin
7.36%
11.4%
16.06%
18.47%
15.48%
12.29%
-5.86%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 6.22% vs 7.74% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is -31.46% vs -23.51% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -4.78% vs -23.62% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 7.04% vs -1.88% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Compare Annual Results Of Themis Medicare With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
405.51
623.23
-217.72
-34.93%
Other Operating Income
0.00
0.00
0.00
Total Operating income
405.51
623.23
-217.72
-34.93%
Raw Material Cost
76.31
213.94
-137.63
-64.33%
Purchase of Finished goods
73.67
68.54
5.13
7.48%
(Increase) / Decrease In Stocks
-17.98
8.84
-26.82
-303.39%
Employee Cost
96.38
112.45
-16.07
-14.29%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
128.09
117.97
10.12
8.58%
Total Expenditure (Excl Depreciation)
356.46
521.74
-165.28
-31.68%
Operating Profit (PBDIT) excl Other Income
49.05
101.49
-52.44
-51.67%
Other Income
4.67
22.48
-17.81
-79.23%
Operating Profit (PBDIT)
53.72
123.97
-70.25
-56.67%
Interest
10.04
1.88
8.16
434.04%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
43.68
122.09
-78.41
-64.22%
Depreciation
9.93
12.90
-2.97
-23.02%
Profit Before Tax
33.74
109.19
-75.45
-69.10%
Tax
9.84
26.84
-17.00
-63.34%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
23.90
82.35
-58.45
-70.98%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
23.90
82.35
-58.45
-70.98%
Share in Profit of Associates
5.93
0.00
5.93
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
29.83
82.35
-52.52
-63.78%
Equity Capital
9.20
20.03
-10.83
-54.07%
Face Value
1.00
10.00
0.00
Reserves
360.43
651.64
-291.21
-44.69%
Earnings per share (EPS)
3.24
41.11
-37.87
-92.12%
Diluted Earnings per share
3.24
41.11
-37.87
-92.12%
Operating Profit Margin (Excl OI)
12.10%
16.28%
0.00
-4.18%
Gross Profit Margin
10.77%
19.59%
0.00
-8.82%
PAT Margin
7.36%
13.21%
0.00
-5.85%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 405.51 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 6.22% vs 7.74% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 29.83 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -31.46% vs -23.51% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 49.05 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -4.78% vs -23.62% in Mar 2024

Annual - Interest
Interest 10.04 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 7.04% vs -1.88% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.10%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has fallen from Mar 2024